Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL

NCT04994210 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Safety and Efficacy

Interventions

DRUG: Sintilimab
DRUG: Chidamide

Sponsor

Sun Yat-sen University